Nintedanib For HER2-Negative Metastatic Inflammatory Breast Cancer (MIBC)
Clinical trial NCT02389764 · TERMINATED
Trial details
- NCT number
- NCT02389764
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-22
- Primary completion
- 2018-06-08
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.